(Q34006269)

30 July 2017

title

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. (English)

1 reference

30 July 2017

1 reference

Klaus W Wagner

1

1 reference

30 July 2017

Elizabeth A Punnoose

2

1 reference

30 July 2017

Thomas Januario

3

1 reference

30 July 2017

David A Lawrence

4

1 reference

30 July 2017

Robert M Pitti

5

1 reference

30 July 2017

Kate Lancaster

6

1 reference

30 July 2017

Dori Lee

7

1 reference

30 July 2017

Melissa von Goetz

8

1 reference

30 July 2017

Sharon Fong Yee

9

1 reference

30 July 2017

Klara Totpal

10

1 reference

30 July 2017

Ling Huw

11

1 reference

30 July 2017

Viswanatham Katta

12

1 reference

30 July 2017

Guy Cavet

13

1 reference

30 July 2017

Sarah G Hymowitz

14

1 reference

30 July 2017

Lukas Amler

15

1 reference

30 July 2017

Avi Ashkenazi

16

1 reference

30 July 2017

language of work or name

English

0 references

publication date

2 September 2007

1 reference

30 July 2017

1 reference

30 July 2017

volume

13

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

1070-1077

1 reference

Cell death: critical control points

30 July 2017

cites work

1 reference

7 January 2021

Promoting apoptosis as a strategy for cancer drug discovery

1 reference

7 January 2021

Cancer biomarkers--an invitation to the table

1 reference

7 January 2021

Death receptors: signaling and modulation

1 reference

7 January 2021

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

1 reference

7 January 2021

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

7 January 2021

Death and anti-death: tumour resistance to apoptosis

1 reference

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

7 January 2021

Targeting death receptors in cancer with Apo2L/TRAIL.

1 reference

7 January 2021

Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.

1 reference

7 January 2021

The chemistry and biology of mucin-type O-linked glycosylation

1 reference

7 January 2021

O-glycosylation of the mucin type

1 reference

7 January 2021

Glycosylation in cellular mechanisms of health and disease

1 reference

7 January 2021

All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases

1 reference

7 January 2021

Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14

1 reference

7 January 2021

Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation

1 reference

7 January 2021

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

1 reference

7 January 2021

Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects

1 reference

7 January 2021

NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility

1 reference

7 January 2021

Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5

1 reference

7 January 2021

A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling

1 reference

7 January 2021

Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis

1 reference

7 January 2021

Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling

1 reference

7 January 2021

Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms

1 reference

7 January 2021

Glycosylation regulates Notch signalling.

1 reference

7 January 2021

The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis.

1 reference

7 January 2021

Pathways of O-glycan biosynthesis in cancer cells

1 reference

7 January 2021

Glycans in cancer and inflammation--potential for therapeutics and diagnostics

1 reference

7 January 2021

The sweet and sour of cancer: glycans as novel therapeutic targets

1 reference

7 January 2021

Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells

1 reference

7 January 2021

Expression profiling--best practices for data generation and interpretation in clinical trials

1 reference

7 January 2021

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients

1 reference

7 January 2021

Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis.

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1627

1 reference

30 July 2017

1 reference